“…Interestingly, administering a FAAH inhibitor is not the only way to examine the effects of elevated AEA on fear conditioning processes - there is also a fairly common functional single nucleotide polymorphism (SNP) in the FAAH gene (C385A; rs324420) that results in lower levels of FAAH protein, and as a result, increased AEA concentrations ( Mayo et al, 2020a , Sipe et al, 2002 , Spagnolo et al, 2016 ). Interestingly, individuals that possess the FAAH C385C → A mutation exhibit elevated AEA concentrations (due to lower FAAH expression) in the amygdala and enhanced fear extinction recall neurocircuitry (i.e., enhanced regulation of amygdala by ventromedial prefrontal cortex; vmPFC), which is in contrast to women with PTSD who typically exhibit altered fear extinction neurocircuitry (e.g., amygdala hyperreactivity, vmPFC and hippocampal hyporeactivity) and poor extinction learning ( Mayo et al, 2021 , Mayo et al, 2020a , Green et al, 2021 ). Similar to FAAH inhibition, in addition to accelerated fear extinction learning ( Dincheva et al, 2015 ), elevated AEA due to this genetic polymorphism has also been linked to decreased anxiety responses following the presentation of stress- and threat-inducing stimuli ( Hariri et al, 2009 ) in healthy humans without a clinical anxiety disorder, and lower hyperarousal symptoms in adults with PTSD ( Spagnolo et al, 2016 ).…”